南方财经1月23日电，宝色股份(300402.SZ)发布公告称，股东山西华鑫海贸易有限公司于2026年1月19 日至2026年1月21日期间通过集中竞价方式减持公司股份。此次减持共涉及2,460,000股，占公司总股本 的0.9968%，减持均价为22.63元/股，对应金额约5567万元。减持后，山西华鑫海持有宝色股份 13,320,000股，持股比例由6.3941%下降至5.3973%。 ...

Core Viewpoint - The medical titanium alloy industry is experiencing significant growth driven by an aging population and increasing chronic disease rates, leading to higher demand for medical devices and implants. The market size for medical titanium alloys in China is projected to reach 4.32 billion yuan in 2024, reflecting a 9% year-on-year increase [1][6]. Group 1: Industry Overview - Medical titanium alloys are specialized biocompatible materials used for manufacturing human implants, characterized by excellent biocompatibility, high specific strength (over 300 MPa·cm³/g), and moderate elastic modulus (approximately 110 GPa) [3]. - The development of medical titanium alloys has progressed through three generations, with the latest generation focusing on reducing toxicity and improving compatibility with human bone [3][4]. Group 2: Market Size and Growth - The market for medical titanium alloys is expected to continue growing, with the orthopedic implant sector (including artificial joints and spinal correction devices) holding the largest market share at 50%, projected to reach 2.16 billion yuan in 2024 [6]. - Factors driving demand in the orthopedic implant sector include an aging population (over 300 million people aged 60 and above in China), advancements in medical technology, and supportive policies [6]. Group 3: Competitive Landscape - The medical titanium alloy industry features a concentrated head with leading companies like Baotai Co., West Superconductor, and Xiangtou Jintian dominating the mid-to-high-end market, while smaller firms focus on niche segments to avoid direct competition [7]. - Key players in the industry include Jiangsu Tiangong Technology Co., Baotai Co., and others, with a focus on R&D and production of titanium and titanium alloy materials [7][8]. Group 4: Industry Trends - The industry is moving towards functional upgrades of materials to meet diverse clinical needs, emphasizing the development of new alloys that are aluminum and vanadium-free for enhanced biocompatibility [9]. - Integration of smart technologies into titanium alloy products is becoming a significant innovation direction, with the incorporation of micro-sensors for real-time monitoring of implant conditions [10]. - The industry is accelerating its green and low-carbon transformation, focusing on energy-efficient production processes and recycling systems for titanium alloy materials to reduce waste and production costs [11].

证券代码：300402 证券简称：宝色股份 公告编号：2026-001 南京宝色股份公司 | 基本情况 1. | | | | --- | --- | --- | | | 信息披露义务人 | 山西华鑫海贸易有限公司 | | | 住所 | 山西综改示范区太原学府园区龙兴街192号1幢4层403室 | | | 权益变动时间 | 2026年1月19日至2026年1月21日 | | | 权益变动过程 | 山西华鑫海因资金需求于2026 年 1月 19 日至 2026 年 1 月 | | | 21 | 日期间，通过深圳证券交易所交易系统以集中竞价方式累计减持公 | 一、股东减持股份触及 1%整数倍的情况 1 | | 司股份2,460,000股，占公司总股本的0.9968%。本次减持后，山西华 | | | | | --- | --- | --- | --- | --- | | | 鑫海持有本公司的股份由15,780,000股减少至13,320,000股，占公司 | | | | | | 总股本的比例由6.3941%减少至5.3973%，减持股份比例触及1%的整 | | | | | 数倍。 | | | | | | | 截至本公 ...

（文章来源：证券日报） 证券日报网讯 1月21日，宝色股份在互动平台回答投资者提问时表示，截至2026年1月20日，公司股东 人数为28238户。 ...

Core Viewpoint - Baose Co., Ltd. focuses on the research, design, manufacturing, and sales of special materials non-standard pressure vessel equipment, primarily involving titanium, zirconium, nickel, and high-grade stainless steel, with applications across various industries [1] Company Overview - The company specializes in non-standard pressure vessel equipment made from special materials, including heat exchangers, towers, reactors, and pipeline fittings [1] - Its products are widely used in chemical, energy, metallurgy, electric power, environmental protection, shipbuilding, and marine engineering sectors [1] Industry Context - The company is positioned as a professional supplier in the domestic special materials non-standard equipment manufacturing field [1] - With the ongoing transformation of the national energy industry and the deepening of the "dual carbon" strategy, the company aims to expand into new business areas [1] - The continuous expansion of downstream application fields for special materials non-standard pressure vessel equipment is expected to drive the company's growth towards new productive forces [1]

Group 1: Company Announcements - Zhongwei Company plans to acquire 64.69% equity of Hangzhou Zhonggui through a combination of share issuance and cash payment, aiming to enhance its capabilities in CMP equipment and solutions [1] - Lixun Precision intends to repurchase shares worth between 1 billion to 2 billion RMB for employee stock ownership plans or equity incentives, with a maximum repurchase price of 86.96 RMB per share [2] - ZaiJing Pharmaceutical has reached a global strategic cooperation and licensing agreement with AbbVie for the development and commercialization of ZG006, receiving an upfront payment of 100 million USD [3] - Tianci Materials expects a net profit increase of 127% to 231% for 2025, driven by significant growth in lithium-ion battery material sales [4] - Meike Home plans to acquire 100% equity of Shenzhen Wande Technology through share issuance and cash payment, with stock resuming trading on January 5, 2026 [6][7] - ST KeliDa is planning a change in control, with stock suspension starting January 5, 2026, due to the transfer of 100% equity of its controlling shareholder [8] - Xinzhou Bang intends to invest approximately 260 million USD in a lithium-ion battery materials project in Saudi Arabia, enhancing its global capacity and supply chain [9] Group 2: Financial Performance - Kid's King anticipates a net profit increase of 51.72% to 82.06% for 2025 [9] - Guangku Technology expects a net profit growth of 152% to 172% for 2025 [9] Group 3: Mergers and Acquisitions - Xidi Micro plans to acquire 100% equity of Chengxin Micro for 310 million RMB [9] - Haili Biological's subsidiary intends to acquire 51% equity of seven dental chain companies for 61.2 million RMB [9]

Core Viewpoint - The company Baose Co., Ltd. has successfully won a public tender for the procurement of a complete set of multi-crystalline silicon reactor equipment for the second phase of the 700-ton ultra-pure multi-crystalline silicon project from Shaanxi Youse Tianhong Ruike Silicon Materials Co., Ltd. [1] Group 1 - The winning bid amount for the project is RMB 273.1 million [1] - A procurement contract has been signed between the company and Tianrui Company [1] - Tianrui Company is considered a related party due to its controlling shareholder being a wholly-owned subsidiary of the company's actual controller, Shaanxi Youse Metal Holding Group Co., Ltd. [1]

Core Viewpoint - Baose Co., Ltd. has successfully won a bid for the procurement project of a complete set of multi-crystalline silicon reactors for the second phase of the 700-ton ultra-pure multi-crystalline silicon project from Shaanxi Youse Tianhong Ruike Silicon Materials Co., Ltd. with a bid amount of 273 million yuan [1] Group 1 - The project bid amount is 273 million yuan [1] - The procurement contract has been signed between Baose Co., Ltd. and Tianhong Ruike [1] - Both companies are under the control of the same parent company, Shaanxi Youse Group, indicating that this transaction is a related party transaction [1]

Core Viewpoint - The company Baose Co., Ltd. has successfully won a public tender for the procurement of a complete set of multi-crystalline silicon reactor equipment for the second phase of the 700-ton ultra-pure multi-crystalline silicon project from Shaanxi Youse Tianhong Ruike Silicon Materials Co., Ltd. [1] Group 1 - The winning bid amount for the project is RMB 273.1 million [1] - A procurement contract has been signed between the company and Tianhong Ruike [1] - The controlling shareholder of Tianhong Ruike, Shaanxi Youse Tianhong New Energy Co., Ltd., holds 81.3107% of the shares and is a wholly-owned subsidiary of Shaanxi Youse Metal Holding Group Co., Ltd., which is the actual controller of the company [1] Group 2 - The transaction constitutes a related party transaction as both the company and Tianhong Ruike are controlled by the same entity, Shaanxi Youse Group, according to the relevant regulations of the Shenzhen Stock Exchange [1]

证券代码：300402 证券简称：宝色股份 公告编号：2025-072 南京宝色股份公司 关于签署中标项目合同暨关联交易的公告 本公司及董事会全体成员保证信息披露的内容真实、准确和完整，没有虚假 记载、误导性陈述或重大遗漏。 一、关联交易基本概述 南京宝色股份公司（以下简称"公司"）于近日参与了陕西有色天宏瑞科硅材 料有限责任公司（以下简称"天瑞公司"）"700 吨超纯多晶硅项目二阶段多晶硅 反应器成套装置采购项目"的公开招标，并成功中标。该项目中标金额为人民币 27,310 万元。公司与天瑞公司签署了该中标项目的采购合同。 由于天瑞公司的控股股东陕西有色天宏新能源有限责任公司（其持有天瑞公司 81.3107%的股权，以下简称"新能源公司"）为本公司实际控制人陕西有色金属控 股集团有限责任公司（以下简称"陕西有色集团"）的全资子公司，因此，本公司 与天瑞公司受同一控制人陕西有色集团控制，根据《深圳证券交易所创业板股票上 市规则》的相关规定，天瑞公司为公司的关联法人，本次交易构成关联交易。 2025 年 12 月 31 日，公司第六届董事会第十七次会议审议通过了《关于公司签 署中标项目合同暨关联交易的议案》，关 ...